Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly paclitaxel steroid premedication de-escalation study in breast cancer
KCT0003651Phase 3Completed
- Sponsor
- Korean Cancer Study Group
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and dexamethasone in breast cancer (2 arms), sponsored by Korean Cancer Study Group. Primary endpoint: All-grade infusion-related reaction incidence. Started Jun 2024; status: completed.
02
Drugs
paclitaxeldexamethasone
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0003651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003651.